These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 31218148)
1. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature. Gajjar K; Luthra P Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148 [TBL] [Abstract][Full Text] [Related]
2. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report. Sarno MJF; Hernandez DPF; Matulac MO Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642 [TBL] [Abstract][Full Text] [Related]
3. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature. Mistry S; Eschler DC AACE Clin Case Rep; 2021; 7(1):17-19. PubMed ID: 33851013 [TBL] [Abstract][Full Text] [Related]
4. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature. Diaz-Ramos A; Eilbert W; Marquez D Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052 [TBL] [Abstract][Full Text] [Related]
5. Fall, Fracture, and Two Episodes of Euglycemic Diabetic Ketoacidosis. Wasey W; Hutchings S; Dufner A; Okon D; Saleh S Cureus; 2022 Jun; 14(6):e25788. PubMed ID: 35812537 [TBL] [Abstract][Full Text] [Related]
6. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip. Zughaib MT; Patel K; Leka M; Affas S Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838 [TBL] [Abstract][Full Text] [Related]
7. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report. Alkatheeri A; Alseddeeqi E J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357 [TBL] [Abstract][Full Text] [Related]
8. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. Andrews TJ; Cox RD; Parker C; Kolb J J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592 [TBL] [Abstract][Full Text] [Related]
9. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old. Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482 [TBL] [Abstract][Full Text] [Related]
10. Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin. Pujara S; Ioachimescu A J Investig Med High Impact Case Rep; 2017; 5(2):2324709617710040. PubMed ID: 28589154 [TBL] [Abstract][Full Text] [Related]
11. The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage. Bińczyk W; Dróżdż O; Siudek B; Głuszczyk AM; Plizga JI; Grajnert FJ Eur J Case Rep Intern Med; 2024; 11(6):004567. PubMed ID: 38846667 [TBL] [Abstract][Full Text] [Related]
12. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report. Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826 [TBL] [Abstract][Full Text] [Related]
13. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report. Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104 [TBL] [Abstract][Full Text] [Related]
14. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors. Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255 [TBL] [Abstract][Full Text] [Related]
15. Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report. Chou YM; Seak CJ; Goh ZNL; Seak JC; Seak CK; Lin CC Medicine (Baltimore); 2018 Jun; 97(25):e11056. PubMed ID: 29923997 [TBL] [Abstract][Full Text] [Related]
16. An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists. Kang CY; Khamooshi P; Reyes Pinzon V Cureus; 2022 Apr; 14(4):e24016. PubMed ID: 35573514 [TBL] [Abstract][Full Text] [Related]
17. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis Followed by Excessively Low Carbohydrate Diet. Tsutsui E; Hoshina Y; Homma H Cureus; 2021 Jul; 13(7):e16085. PubMed ID: 34345561 [TBL] [Abstract][Full Text] [Related]
18. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections? Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692 [TBL] [Abstract][Full Text] [Related]
19. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Patel K; Nair A Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965 [TBL] [Abstract][Full Text] [Related]
20. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery. Osafehinti DA; Okoli OJ; Karam JG AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]